Clinical Trial

Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

Suspended Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
PI Request
Summary
To learn if Hyperpolarized C-Pyruvate Magnetic Resonance (HP-MR) Spectroscopic Imaging can help doctors detect low-risk (benign) and high-risk (malignant) cysts.
Protocol Amendment History 2 changes
critical Recruitment suspended 2026-08-14
critical Recruitment suspended: PI Request 2026-08-14
Trial Details
NCT Number NCT05873699
Lead Sponsor M.D. Anderson Cancer Center
Conditions Pancreatic Cyst
Enrollment 20 participants
Start Date 2023-08-18
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-13